Clinical Trial Update: ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for beta-thalassemia major using autologous CD34+ cells transduced with TNS9.3.55, a lentiviral vector encoding the normal beta-gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major

Drugs mentioned

• TNS9.3.55 lentiviral vector encoding the normal human beta-globin gene

Snippet

Sponsor: San Rocco Therapeutics | Conditions: Confirmed Diagnosis of ß-thalassemia Major | Phase 1 | Status: ACTIVE_NOT_RECRUITING